Eric Darby

Eric Darby
Eric C. Darby, MD, FACS received his undergraduate degree in Biology from Washington University in St. Louis, Missouri. Following his undergraduate studies, he earned his Doctor of Medicine at New York Medical College in Westchester County, New York. He completed a residency in General Surgery and a residency in Urologic Surgery at New York Medical College’s Westchester Medical Center. Dr. Darby specializes in the treatment of various urologic conditions including urinary tract infections, kidney stones, prostate cancer, bladder cancer, and testicular cancer. He is dedicated to utilizing minimally-invasive, innovative therapies for patients suffering from urinary incontinence, kidney stones, and benign prostatic hyperplasia (BPH). Highly respected among his peers, he has served as Chief of Staff and Vice Chief for Mary Immaculate Hospital in Newport News. Dr. Darby is board certified in Urology, a Diplomat of the American Board of Urology, and a Fellow of the American College of Surgeons. He has been practicing in Newport News since 1998.
Medical School:

New York Medical College


Westchester Medical Center

All surgical treatments have inherent and associated side effects. Individual’s outcomes may depend on a number of factors, including but not limited to patient characteristics, disease characteristics and/or surgeon experience. The most common side effects are mild and transient and may include mild pain or difficulty when urinating, discomfort in the pelvis, blood in the urine, inability to empty the bladder or a frequent and/or urgent need to urinate, and bladder or urinary tract infection. Other risks include ejaculatory dysfunction and a low risk of injury to the urethra or rectum where the devices gain access to the body for treatment. Further, there may be other risks as in other urological surgery, such as anesthesia risk or the risk of infection, including the potential transmission of blood borne pathogens. For more information about potential side effects and risks associated with Aquablation therapy for Benign Prostatic Hyperplasia (BPH) treatment, speak with your urologist or surgeon. Prior to using our products, please review the Instructions for Use, Operator’s Manual or User Manual, as applicable, and any accompanying documentation for a complete listing of indications, contraindications, warnings, precautions and potential adverse events. No claim is made that the AquaBeam Robotic System will cure any medical condition, or entirely eliminate the diseased entity. Repeated treatment or alternative therapies may sometimes be required.

Rx Only